Pathstone Holdings
MIST icon

Pathstone Holdings’s Milestone Pharmaceuticals MIST Stock Holding History

Pathstone Holdings’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Sell
17,040
-1,000,000
-98% -$1.75M ﹤0.01% 2206
2025
Q4 		$2.1M Buy
1,017,040
+17,040
+2% +$36.7K 0.01% 1002
2025
Q3 		$2M Buy
+1,000,000
New +$1.76M 0.01% 1029

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Pathstone Holdings's MIST Position: Q1 2026 in Review

Pathstone Holdings reduced its Milestone Pharmaceuticals (MIST) stake by 98% in Q1 2026, selling an estimated $1.75M and leaving 17,040 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Pathstone Holdings first reported a position in MIST in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.1M in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Pathstone Holdings held 17,040 shares of Milestone Pharmaceuticals worth $20.3K as of Q1 2026.
  • Pathstone Holdings sold 1,000,000 Milestone Pharmaceuticals shares in Q1 2026, an estimated $1.75M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #2206 holding.
  • Pathstone Holdings first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Pathstone Holdings's Milestone Pharmaceuticals position peaked at $2.1M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.